Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07124858) titled 'Prospective National Cohort Evaluating Prognostic Factors for Efficacy of Fruquintinib Treatment in Patients With Metastatic Colorectal Cancer' on Aug. 8.
Study Type: Interventional
Study Design:
Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Other. Masking: None (Open Label).
Primary Sponsor: Federation Francophone de Cancerologie Digestive
Condition:
Metastatic Colorectal Cancer (CRC)
Antineoplastic Agents, Immunological
VEGFR-TKI
Intervention:
Drug: Fruquintinib
Recruitment Status: Not recruiting
Phase: N/A
Date of First Enrollment: March 1, 2026
Target Sample Size: 300...